Synthetic Blood International Adds New Scientific Consultant
BusinessWire, Monday, July 20, 1998 at 09:18
KETTERING, Ohio--(BUSINESS WIRE)--July 20, 1998--Synthetic Blood
International Inc. (SYBD) announced today that William V. Walter,
Ph.D., President of Walter Pharmaceutical Consultants Inc., has
agreed to serve as a scientific consultant for the company's
perfluorocarbon product formulation and pulmonary drug delivery
efforts.
Dr. Walter holds a Ph.D. in physical chemistry from Notre Dame
and was the recipient of a postdoctoral fellowship in pharmaceutical
chemistry at the California Institute of Technology. He previously was
Director of Product Development at McGaw Laboratories where he was
instrumental in developing their nutritional fat emulsion and drug
delivery systems. His experience at SynZyme Technologies as Vice
President of Regulatory Affairs includes work with hemoglobin-based
blood substitutes.
"We are very pleased to secure the services of Dr. Walter. His
experience with nutritional emulsions and hemoglobin-based blood
substitutes will provide valuable support to our Oxycyte blood
substitute program and assist SYBD in identifying and evaluating
unique, new, second generation blood substitute formulas," said Robert
Nicora, President. "Additionally, we expect him to help the company
define and focus its perfluorocarbon drug delivery program which
represents an exciting new area for SYBD that may generate additional
products."
SYBD is developing Oxycyte, a perfluorocarbon blood substitute
emulsion; Fluorovent, a perfluorocarbon liquid ventilation product;
and an implanted biosensor for continuous monitoring of blood glucose
levels in diabetics
SYBD is located in Kettering, Ohio and has a West Coast office in
Irvine, California. The company's stock is traded on the OTC
Electronic Bulletin Board, symbol SYBD.
CONTACT: Synthetic Blood International Inc.
Joan Mahan, 800/809-6054
KEYWORD: OHIO CALIFORNIA
INDUSTRY KEYWORD: MEDICINE
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 1998, Business Wire |
